Management of Staff Member Bitten by HCV-Positive Person
Immediately wash the bite wound thoroughly with soap and water, then proceed with baseline testing and serial follow-up for HCV infection—no postexposure prophylaxis is available or recommended for hepatitis C. 1
Immediate Actions (Within Hours)
Wound care:
- Wash the bite wound and surrounding skin thoroughly with soap and water
- Do not squeeze or manipulate the wound excessively 1
Source patient testing:
- Confirm the source patient's HCV status with anti-HCV antibody testing (use rapid testing if available)
- Also test the source for HBsAg and HIV antibody, as co-infection is possible and changes management 1
Exposed staff member baseline testing:
- Draw baseline blood for anti-HCV antibody and ALT (alanine aminotransferase)
- Store this baseline serum for at least 2 years 2
- Assess hepatitis B vaccination status and provide post-exposure prophylaxis if indicated
- Consider HIV post-exposure prophylaxis if source is HIV-positive or status unknown
Critical Point: No HCV Prophylaxis Available
There is no vaccine or post-exposure prophylaxis for hepatitis C. The guidelines are explicit: "HCV: PEP not recommended" 1. While one small study suggested pre-emptive interferon might have some benefit 3, this approach is not supported by major guidelines and has been abandoned in practice.
Follow-Up Testing Protocol
The CDC guidelines provide two pathways depending on whether early treatment is being considered:
Standard Follow-Up (Most Common Approach)
- Baseline and 4-6 months post-exposure: Test for anti-HCV and ALT 1
- Optional earlier diagnosis: Perform HCV RNA testing at 4-6 weeks if earlier diagnosis is desired 1
- Confirm any repeatedly reactive anti-HCV enzyme immunoassays with supplemental tests 1
Enhanced Monitoring (If Early Treatment Planned)
European guidelines suggest more intensive monitoring if early antiviral treatment during acute phase is the institutional strategy:
- Baseline: Anti-HCV and ALT
- Monthly ALT for 4 months after exposure
- Qualitative HCV RNA when ALT elevation is detected 4
The UK approach recommends testing at 6,12, and 24 weeks:
- HCV RNA at 6 and 12 weeks
- Anti-HCV at 12 and 24 weeks 2
Risk Assessment
The transmission risk from a bite resulting in blood exposure is approximately 1.8-3% for needlestick injuries 5, though bite transmission risk may be lower depending on whether blood was actually transferred. The bite must result in blood exposure to pose significant risk 1.
If HCV Infection Develops
Early treatment of acute HCV infection is highly effective. Recent evidence shows that treating acute HCV infection with direct-acting antivirals (DAAs) achieves cure rates approaching 98-99% 6, 7. This is far superior to waiting for chronic infection to develop.
Key action: If HCV RNA becomes positive or anti-HCV seroconverts, immediately refer to a hepatologist or infectious disease specialist experienced in HCV treatment 2, 6. Early interferon treatment (in the pre-DAA era) showed high efficacy, and modern DAAs are even more effective with fewer side effects 7.
Counseling Points
- Advise the staff member to seek immediate medical evaluation for any acute illness during the follow-up period, particularly symptoms suggesting acute hepatitis (fatigue, jaundice, right upper quadrant pain) 1
- Provide emotional support and access to counseling services 1
- During the follow-up period, advise precautions to prevent secondary transmission (safe sex practices, no blood/organ donation) 1
- The staff member should report any symptoms of liver disease even after the formal follow-up period ends 2
Common Pitfalls to Avoid
- Do not give interferon prophylactically—it is not recommended and evidence shows minimal benefit 3
- Do not stop at antibody testing alone—if anti-HCV is positive, you must perform HCV RNA to distinguish active infection from resolved infection 8
- Do not forget to test for HBV and HIV—the source patient may have multiple bloodborne infections requiring different management 1
- Do not delay referral if infection occurs—early treatment dramatically improves outcomes 6, 7
- Ensure complete testing—approximately one-third of HCV testing historically has been incomplete when RNA is not performed after positive antibody 8